Skip to main content
PMVP logo

PMVP · PMV Pharmaceuticals, Inc. · Executive Compensation

Track PMVP — free
$1.27 +0.06 (+4.96%) At close · Nov 13
Market Cap
$95.93M
Shares
75.53M
Volume · Nov 13 290.84K Avg daily vol (3M) 676.77K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
David H. Mack $1,665,191
Robert Ticktin $861,206
Fiscal 2024
Executive Total
David H. Mack $4,760,281
Deepika Jalota $1,929,014
Michael Carulli $1,379,515
Fiscal 2023
Executive Total
David H. Mack $2,209,795
Winston Kung $1,260,259
Deepika Jalota $1,097,198
Fiscal 2022
Executive Total
David H. Mack $3,576,440
Winston Kung $1,768,476
Deepika Jalota —
Fiscal 2021
Executive Total
David H. Mack $3,541,855
Winston Kung $1,665,259
Leila Alland $1,400,292
Deepika Jalota $1,026,863
Fiscal 2020
Executive Total
Leila Alland $1,674,649
David H. Mack $1,314,113
Winston Kung $825,365
Deepika Jalota $532,673
Fiscal 2019
Executive Total
David H. Mack $628,110
Winston Kung $562,440
Deepika Jalota $517,138

Executive changes

Person Change Filed
Dr. Matthew Eckler Appointed 2026-10-05
Leila Alland Resigned 2024-01-05
Winston Kung Resigned 2024-01-05
Winston Kung Resigned 2024-01-05
Michael Carulli Appointed 2024-01-05
Carol Gallagher, Pharm.D. Appointed 2022-11-04
Thilo Schroeder, Ph.D. Resigned 2022-11-04

Leadership

Key facts CIK 1699382 CUSIP 69353Y103 13F (30d) 50 filings 38 filers Visit website Investor relations